Skip to content
  • twitter
  • linkedin
  • onxeo
  • SUBSCRIBE TO OUR NEWS
  • EN
  • FR
  • CONTACT
Onxeo

Onxeo

Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.

  • COMPANY
    • Profile
    • Executive Committee
    • Board of Directors
    • Join us
    • Contact us
  • SCIENCE
    • DNA Damage Response
    • platON™
    • Collaborations
  • PRODUCTS
    • DDR Pipeline
    • AsiDNA™
    • OX401
    • Other
  • INVESTORS
    • Regulated Information
      • Press Releases
      • Registration documents
      • Financial Information
      • Shares & Voting Rights
      • Share Repurchase/ Liquidity Agreement
      • Financial operations
    • Governance
      • Board Committees & Regulations
      • Directors’ Disclosures
      • Bylaws
    • Shareholder Resources
      • General Meetings
      • Financial Calendar
      • Stock Information
      • Shareholders’ Letters
    • Investor Relations
  • NEWS & EVENTS
    • Press Releases
    • Events & Presentations
    • Shareholder Letters
    • Media

General meetings

    2. >
  2. Investors
    3. >
  3. Shareholder Resources
    4. >
  4. General meetings

general meetings of shareholders

General Meetings 2020

Documentation

General Meetings 2019

Documentation

General Meetings 2018

Documentation

General Meetings 2017

Documentation

General Meeting 2016

Documentation

General Meetings 2015

Documentation

INVESTORS

  • REGULATED INFORMATION
    • Press Releases
    • Registration Documents
    • Financial Information
    • Number of Shares and Voting Rights
    • Share Repurchase – Liquidity Agreement
    • Financial operations
  • GOVERNANCE
    • Board Committees & Regulations
    • Directors’ Disclosures
    • Bylaws
  • SHAREHOLDER RESOURCES
    • General Meetings
    • Financial Calendar
    • Stock Information
    • Shareholder Letters
  • INVESTOR RELATIONS


AMF REGULATED INFORMATION

Onxeo

> SITE MAP

> LEGAL NOTICES
> FOLLOW US

COMPANY

COMPANY


  • Profile
  • Executive Committee
  • Board of Directors
  • Join us
  • Contact us

SCIENCE

SCIENCE


  • DNA Damage Response
  • platON™
  • Collaborations

PRODUCTS

PRODUCTS


  • Pipeline
  • AsiDNA™
  • OX401
  • belinostat / Beleodaq®

INVESTORS

INVESTORS


  • Regulated Information
  • Governance
  • Shareholder Resources
  • Investor Relations

NEWS AND EVENTS

NEWS & RELEASES


  • Press Releases
  • Events & Presentations
  • NewsLetters
  • Media
SUBSCRIBE TO
OUR NEWS
CONTACT
US

ONXEO SA


49, avenue du Général Martial Valin
75015 PARIS – FRANCE
+33 (0) 1 45 58 76 00

© Copyright 2019 Onxeo
Photos : Onxeo - Design : 1sur1.net

Copyright © 2021 Onxeo All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress